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Dear Editors,
We thank Dr. Taguchi [1] for his interest in our article [2]
and would like to respond to the points he raises as follows:
1. Our new method of computerized alveolar bone density
measurement (Bone Right®) was not applied to the
panoramic radiograms presented in Figs. 2 and 3 for the
purpose of providing the outline of the dental problems
of these patients. As pointed out by Dr. Taguchi,
panoramic radiograms have disadvantages for quanti-
tative radiography.
2. Our computerized alveolar bone density measurement
(Bone Right®) is entirely different from Kribb’s method
directly comparing the radiographic density of alumi-
num step wedge pasted on a dental X-ray film with that
of the alveolar bone. In our method aluminum step
wedgeisusedtostandardizethemeasurementsimply for
inter-measurement comparison. Exposure is strictly
controlled by the Bone Right method based on the
thickness and structure of the alveolar bone, so that the
most efficient exposure time is automatically selected in
each case including Case 5, so that the intra- and inter-
measurement comparison is kept to the minimum.
3. The occurrence of condensing osteitis naturally cannot
be absolutely excluded. The increase of alveolar bone
mineral density not only in areas adjacent to the site of
osteonecrosis or osteomyelitis, but also at other sites
remote from the lesion, would strongly point out to the
generalized changes of alveolar bone density rather
than the consequence of the jaw necrosis. The threshold
level of the increase of alveolar bone mineral density is
estimated to be around 170 based on the data collected
so far.
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